Home BrainVectis

BrainVectis

acquired
Series A
Developer of Gene Therapy for Neurodegenerative Diseases

Basic Information

BrainVectis Develops Gene Therapies for Neurodegenerative Diseases by Targeting Cholesterol Pathways in the Brain
BrainVectis
Ile-de-France,France
less than 15 people
January 01, 2015
--